Kanagawa, Japan

Takahiro Nishimoto



Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Hamura, JP (2016)
  • Kanagawa, JP (2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takahiro Nishimoto: Innovator in Pharmaceutical Chemistry

Introduction

Takahiro Nishimoto is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Nishimoto holds 2 patents that showcase his innovative work. His latest patents include a pyrimidine derivative, which is a compound represented by a specific formula. This compound exhibits mPGES-1 inhibitory action, making it useful as an active ingredient in medications for the prophylactic and therapeutic treatment of inflammation, pain, and rheumatism. Additionally, he has developed a heterocyclic compound that serves as an H1 receptor antagonist, providing potential benefits as an antiallergic agent.

Career Highlights

Nishimoto is associated with Aska Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in the pharmaceutical sector. His work has contributed to the creation of innovative solutions for various medical conditions.

Collaborations

Throughout his career, Nishimoto has collaborated with notable colleagues, including Makoto Okada and Youichi Nakano. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Takahiro Nishimoto's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…